Pancreatic cancer, oncogene and anti-oncogene

World Chinese Journal of Digestology

Volumn 9, Issue 1, 2001, Pages 72-73

  Liu, J W ^a   Li, K Z ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ONCOGENE; PROSTATE CANCER; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0035132130     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas
2. Genetic basis of cancer of pancreas: Diagnostic and therapeutic applications
3. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
4. K-ras mad p53 gene mutations in pancreatic cancer: Ductal and nonductal tumor progress through different genetic lesions
5. K-ras mutations and allelic loss at 5q and 18q in development of human pancreatic cancers
6. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: Diagnostic utility and pancreatic significance
7. C-erbB-2 expression predicts tamoxifen efficacy in breast cancer patients
8. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
9. The biology of erbB-2/neu/HER-2 and its role in cancer
10. Overexpression of HER2/neu oncogene in human pancreatic carcinoma
11. HER-2/Neu expression as a progression marker in pancreatic intraepithelial neoplasia
12. Prognosis of human pancreatic adenocarcinoma: Review of clinical and histopathological variables and possible use of new molecular methods
13. Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma
14. P53: At the crossroads of molecular carcinogenesis and risk assessment
15. p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness
16. Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinoma
17. Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer
18. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma
19. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
20. Tumor-suppressive pathways in pancreatic carcinoma
21. 4/Smad4 gene in neuroendocrine pancreatic tumor
22. P16 and K-ras gene mutations in the intraductual precursors of human pancreatic adenocarcinoma
23. 1 in pancreatic tumors
24. 1 and DCC tumor suppressor genes: Uncommon in human pancreatic adenocarcinoma
25. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma